Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Thyroid Carcinoma, Anaplastic × ceritinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Carcinoma, Anaplastic 1 Lymphoma, Large-Cell, Anaplastic 1 Hematologic Neoplasms 1

Interventions

vandetanib 1 trametinib 1 fosbretabulin 1 dabrafenib 1 combretastatin 1 ceritinib 1 Paclitaxel 1 Docetaxel 1 Carboplatin 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02289144 2019-07-30

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

University of Texas Southwestern Medical Center

Phase 2 Withdrawn

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡